Skip to main navigation Skip to search Skip to main content

Ledipasvir/sofosbuvir effectively treats hepatitis c virus infections in an underserved population

  • Rachel A. Stewart
  • , Brooke R. Macdonald
  • , Tzu Chun Chu
  • , Jonathan D. Moore
  • , Esther O. Fasanmi
  • , Rohit P. Ojha

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)3233-3240
Number of pages8
JournalDigestive Diseases and Sciences
Volume63
Issue number12
DOIs
StatePublished - Jul 16 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 1 - No Poverty
    SDG 1 No Poverty
  2. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus Subject Areas

  • Physiology
  • Gastroenterology

Keywords

  • Direct-acting antivirals
  • Hepatitis C virus
  • Inequalities
  • Safety-net
  • Underserved

Fingerprint

Dive into the research topics of 'Ledipasvir/sofosbuvir effectively treats hepatitis c virus infections in an underserved population'. Together they form a unique fingerprint.

Cite this